Category: Markets
Published: 2026-07-07T14:05:16.000Z
Hodges Capital Management Inc. significantly increased its stake in Amgen Inc. by 75.4% in the first quarter, purchasing an additional 3,620 shares to bring its total holdings to 8,424 shares valued at $2.96 million. This increase follows strong quarterly results from Amgen, with EPS of $5.15 and revenue of $8.62 billion beating estimates, leading the company to raise its full-year 2026 guidance. Despite a "Hold" consensus from analysts, sentiment is mixed, with some upgrades and price target increases, though concerns persist regarding Tavneos scrutiny and relative stock underperformance.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.